-
Something wrong with this record ?
Regulation of drug transporter expression and function in the placenta
F. Staud, M. Ceckova,
Language English Country England, Great Britain
Document type Journal Article, Research Support, Non-U.S. Gov't, Review
- MeSH
- Biological Transport physiology MeSH
- Drug Interactions MeSH
- Humans MeSH
- Maternal-Fetal Exchange physiology MeSH
- Membrane Transport Proteins genetics metabolism MeSH
- Placenta metabolism MeSH
- Pregnancy MeSH
- Xenobiotics adverse effects pharmacokinetics MeSH
- Animals MeSH
- Check Tag
- Humans MeSH
- Pregnancy MeSH
- Female MeSH
- Animals MeSH
- Publication type
- Journal Article MeSH
- Research Support, Non-U.S. Gov't MeSH
- Review MeSH
INTRODUCTION: Medication of pregnant women is increasingly common in developed countries. Several placental drug transporters have been shown to transfer their substrates from the trophoblast back to the maternal circulation, thus hindering the transplacental passage of xenobiotics and protecting the fetus. However, the expression and activity of drug transporter proteins in the placenta vary during gestation and are tightly regulated by many factors. In addition, their function can be compromised by pathological conditions and/or drug-drug interactions. AREAS COVERED: This article reviews current knowledge on placental drug transporters, their effects on placental pharmacokinetics and the regulatory mechanisms that control their expression and activity. Transcriptional, genetic and epigenetic mechanisms of placental transporter regulation and the drug-drug interactions that modulate transporter activity are described. Physiological and pathological factors that can affect drug transporter expression and function in the placenta are also discussed. EXPERT OPINION: The expression and activity of drug transporter proteins in the placenta vary during gestation and are tightly regulated by many factors. Subsequently, there is a great variability in the expression and function of placental drug transporters both within human populations (interindividual variability) and also during gestation (intraindividual variability). An understanding of the expression and function of placental drug transporters is essential for efficient and safe therapy during pregnancy. There is clearly a need for further preclinical and clinical studies on placental drug transporters, but such investigations must be carefully designed and the resulting data should be evaluated with great caution. This review highlights several methodological aspects that will have to be considered and addressed in order to shed further light on these important issues.
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc16000367
- 003
- CZ-PrNML
- 005
- 20160125111357.0
- 007
- ta
- 008
- 160108s2015 enk f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1517/17425255.2015.1005073 $2 doi
- 035 __
- $a (PubMed)25600150
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a enk
- 100 1_
- $a Staud, Frantisek $u Charles University in Prague, Department of Pharmacology and Toxicology, Faculty of Pharmacy in Hradec Kralove , Heyrovskeho 1203, 50005 Hradec Kralove , Czech Republic +420 495 067 407 ; +420 495 067 170 ; frantisek.staud@faf.cuni.cz.
- 245 10
- $a Regulation of drug transporter expression and function in the placenta / $c F. Staud, M. Ceckova,
- 520 9_
- $a INTRODUCTION: Medication of pregnant women is increasingly common in developed countries. Several placental drug transporters have been shown to transfer their substrates from the trophoblast back to the maternal circulation, thus hindering the transplacental passage of xenobiotics and protecting the fetus. However, the expression and activity of drug transporter proteins in the placenta vary during gestation and are tightly regulated by many factors. In addition, their function can be compromised by pathological conditions and/or drug-drug interactions. AREAS COVERED: This article reviews current knowledge on placental drug transporters, their effects on placental pharmacokinetics and the regulatory mechanisms that control their expression and activity. Transcriptional, genetic and epigenetic mechanisms of placental transporter regulation and the drug-drug interactions that modulate transporter activity are described. Physiological and pathological factors that can affect drug transporter expression and function in the placenta are also discussed. EXPERT OPINION: The expression and activity of drug transporter proteins in the placenta vary during gestation and are tightly regulated by many factors. Subsequently, there is a great variability in the expression and function of placental drug transporters both within human populations (interindividual variability) and also during gestation (intraindividual variability). An understanding of the expression and function of placental drug transporters is essential for efficient and safe therapy during pregnancy. There is clearly a need for further preclinical and clinical studies on placental drug transporters, but such investigations must be carefully designed and the resulting data should be evaluated with great caution. This review highlights several methodological aspects that will have to be considered and addressed in order to shed further light on these important issues.
- 650 _2
- $a zvířata $7 D000818
- 650 _2
- $a biologický transport $x fyziologie $7 D001692
- 650 _2
- $a lékové interakce $7 D004347
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a maternofetální výměna látek $x fyziologie $7 D008431
- 650 _2
- $a membránové transportní proteiny $x genetika $x metabolismus $7 D026901
- 650 _2
- $a placenta $x metabolismus $7 D010920
- 650 _2
- $a těhotenství $7 D011247
- 650 _2
- $a xenobiotika $x škodlivé účinky $x farmakokinetika $7 D015262
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 655 _2
- $a přehledy $7 D016454
- 700 1_
- $a Ceckova, Martina
- 773 0_
- $w MED00183846 $t Expert opinion on drug metabolism & toxicology $x 1744-7607 $g Roč. 11, č. 4 (2015), s. 533-55
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/25600150 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20160108 $b ABA008
- 991 __
- $a 20160125111519 $b ABA008
- 999 __
- $a ok $b bmc $g 1102648 $s 924573
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2015 $b 11 $c 4 $d 533-55 $e 20150120 $i 1744-7607 $m Expert opinion on drug metabolism & toxicology $n Expert Opin Drug Metab Toxicol $x MED00183846
- LZP __
- $a Pubmed-20160108